Rio de Janeiro, Brazil, recently hosted what will probably be one of the last in-person neurology conferences for some time. The first [Global Stroke Alliance meeting](http://globalstroke2020.com/en/home-3/){#interrefs10}, held on March 11--13, 2020, ended a day early because of the COVID-19 pandemic, and many participants could join only remotely as travel became restricted. Nonetheless, participants heard about several promising initiatives to prevent and treat stroke in Latin America and across the world. A few weeks on, preventing stroke and improving stroke care seem even more challenging than before COVID-19, but these goals remain crucial if we are to reduce the global burden of stroke and ensure that stroke services are resilient in difficult times.

According to the Global Burden of Diseases, Injuries and Risk Factors [study](http://dx.doi.org/10.1016/S1474-4422(18)30499-X){#interrefs20}, 5·5 million deaths and 116·4 million disability-adjusted life years were attributable to stroke in 2016; stroke was the leading cause of neurological disability in almost all regions, including Latin America. Against this backdrop, the aim of the Global Stoke Alliance [meeting](https://www.world-stroke.org/news-and-blog/news/global-stroke-alliance-meeting-report){#interrefs30} was "to stimulate a global alliance to improve stroke care worldwide." As an example of the close international collaboration taking place, the congress included the 2nd Latin American Stroke Ministerial Meeting, attended by representatives of 11 national Ministries of Health and the Pan American Health Organization. Participants reviewed progress since 2018, when representatives from 13 countries met at the first such meeting in Gramado, Brazil, and committed to the [Declaration of Gramado](http://dx.doi.org/10.1016/S1474-4422(19)30068-7){#interrefs40}---a set of priorities and recommendations for stroke prevention, treatment, and research. The high burden of stroke in many of these countries requires a coordinated response, and stroke specialists have been working hard to come up with affordable solutions.

The Global Stroke Alliance meeting also saw the official launch of the World Stroke Organization (WSO) Cut Stroke in Half [campaign](https://www.world-stroke.org/about-wso/presidents-platform/wso-launches-strategy-to-cut-stroke-in-half){#interrefs50}, which was first announced in [October, 2019](https://doi.org/10.1016/S1474-4422(19)30317-5){#interrefs60}. This campaign aims to reduce the incidence of stroke in people who are at risk, by motivating individuals to make lifestyle changes (through the work of community health workers and technology such as smartphone applications) and by use of a low-dose combination therapy (polypill). With 80--90% of strokes attributable to lifestyle risk factors, the potential of such an initiative is huge. The plans announced in Rio de Janeiro include roll out of the community and technology aspects of the campaign in Brazil and a clinical trial to test the polypill, although the need for social distancing and the demands of the COVID-19 pandemic on health-care systems seem likely to delay progress.

Discussion of findings from the [RESILIENT trial](https://clinicaltrials.gov/ct2/show/NCT02216643){#interrefs70}, of mechanical thrombectomy versus usual care in people with anterior circulation large vessel occlusion, raised hopes and questions at the Global Stroke Alliance meeting. As initially reported at the 2019 European Stroke Organisation (ESO) Conference, the trial was terminated early following evidence of efficacy in the first interim [analysis](https://journals.sagepub.com/doi/full/10.1177/2396987319848123#_i32){#interrefs80}. Publication of the full results is eagerly awaited but they are expected to show that mechanical thrombectomy, which is efficacious in largely white populations in high-income countries, is also beneficial in patients with significantly lower socioeconomic status and from other ethnic backgrounds, even when implemented in under-resourced settings, such as the public health-care systems of low-income countries.

Since mid-March, a lot has changed in all areas of life, including stroke research and care for patients. The joint ESO-WSO Conference that was due to take place in Vienna, Austria, on May 12--15, 2020, has been postponed, to Nov 7--9, 2020. A statement from the [WSO president](https://www.world-stroke.org/news-and-blog/news/stroke-care-and-the-covid19-pandemic){#interrefs90} stresses that the WSO fully supports "all priority measures to treat COVID-19 patients as needed" but also raises concerns about the effects of the pandemic on stroke services. Experiences from around the world being shared on the WSO website include reports of people with minor strokes not seeking medical attention, delays to acute stroke treatment owing to the need for COVID-19 testing and isolation, and some clinical trials being halted to reduce non-essential contact between people.

While the COVID-19 pandemic continues, the vital work of caring for stroke patients is likely to be even more challenging than usual. Initiatives to reduce the burden of stroke such as those that seemed so promising in Rio de Janeiro might need to be paused. However, prevention of stroke and mechanical thrombectomy have the potential to reduce the burden of stroke substantially, for health services as well as individuals. Work such as that of the Global Stroke Alliance must maintain its momentum and move forward as soon as it is safe to do so.
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